首頁 > 市場調查報告書 > 醫療設備

整形外科美容整形

市場調查報告書

商品編碼

1378510

去細胞真皮基質市場：依來源、應用、地點和區域分類

Acellular Dermal Matrices Market, By Origin, By Application (Acute Wounds Chronic Wounds, and Reconstruction Procedures ), By Place of Setting (Hospitals, Ambulatory Surgical Centers, and Office Based), and By Region

出版日期: 2023年10月13日 | 出版商:

Coherent Market Insights | 英文 271 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2023 年，全球去細胞真皮基質市場規模將達到 88 億美元，預測期內（2023-2030 年）年複合成長率為 12.1%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	88億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	12.10%	2030年市場規模預測	196億美元

圖 1. 2023 年去細胞真皮基質的全球市場佔有率(%)（按來源分類）

去細胞真皮基質 (ADM) 是一種軟結締組織移植物，透過去細胞程序創建，使細胞外真皮基質保持完整。一旦植入體內，該結構將充當供體側細胞的支架，促進未來的整合和再灌注。最初，去細胞真皮基質用於燒傷表面重建、腹壁修復、鼓膜置換、硬腦膜修復和牙齦移植。 ADM目前主要應用於乳房外科和整形外科。此外，去細胞真皮基質還可用於治療急性傷口，如燒傷、外傷、癌症和感染疾病，以及慢性傷口，如糖尿病足潰瘍、靜脈性腿部潰瘍和壓瘡。

市場動態

市場參與者正在致力於推出和核准用於重組等各種應用的新產品，預計這將在預測期內推動全球去細胞真皮基質市場的成長。例如，2023年5月，最大的人體組織供應商之一AlloSource推出了AlloMend Duo Acellular Dermal Matrix (ADM)，這是軟組織重組的天然替代。 Aromend Duo ADM 的發展是為了幫助外科醫生在修復和重組軟組織異常時確保長期結構穩定性。 Aromendo Duo ADM 的特性具有多種優勢，使其適用於需要人體再生組織基質強度和生物相容性的各種健康治療。這種同種異體移植物靈活且柔韌，可實現理想的操作和精確的植入。

本研究的主要特點

該研究報告對全球去細胞真皮基質市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率(CAGR)。
它還闡明了各個細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
它根據公司亮點、產品系列、主要亮點、業績和策略等參數，介紹了全球去細胞真皮基質市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出資訊的決策。
全球脫細胞真皮基質市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球去細胞真皮基質市場的各種策略矩陣，將促進相關人員的決策。

公司簡介
- Integra LifeSciences Corporation
- AbbVie Inc.
- Johnson &Johnson
- HansBioMed
- Becton, Dickinson and Company
- Cook Group
- Smith &Nephew Plc.
- Reprise Biomedical
- Organogenesis Holdings Inc.
- Tissue Regenix
- LifeNet Health
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation
- MiMedx Group
- PolyNovo Limited
- Fidia Pharma USA Inc.
- Baxter International Inc.
- In2Bones Global
- BioHorizons, Inc.
- Harbor MedTech, Inc.
- MLM Biologics Inc.
- Geistlich Pharma AG
- Olaregen Therapeutix, Inc.
- EnColl Corporation
- Kerecis limited
- DSM
- ACell Inc.
- 3M
- Cell Constructs I, LLC
- CG bio Inc.
- Marine Polymer Technologies, Inc.
分析師觀點

第10章章

調查方法

簡介目錄

Product Code: CMI4362

Global acellular dermal matrices market is estimated to be valued at US$ 8.8 Bn in 2023, and is expected to exhibit a CAGR of 12.1% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 8.8 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	12.10%	2030 Value Projection:	US$ 19.6 Bn

Figure 1. Global Acellular Dermal Matrices Market Share (%), By Origin, 2023

Acellular dermal matrix (ADM) is a soft connective tissue graft created by a decellularization procedure that leaves the extracellular skin matrix intact. This structure, once implanted in the body, acts as a scaffold for donor-side cells, facilitating future integration and revascularization. Initially, acellular dermal matrices were employed in burn resurfacing, abdominal wall repair, tympanic membrane replacement, dural repairs, and gingival grafting. ADMs are now mostly employed in breast surgery and plastic surgery. Furthermore, acellular dermal matrices are used for treating acute wounds such as burns, traumatic wounds, cancer, and infections, as well as chronic wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, and others.

Market Dynamics

Market players are engaged in new product launches or approvals for various applications such as tissue reconstruction, and this is expected to drive the global acellular dermal matrices market growth over the forecast period. For instance, in May 2023, AlloSource, one of the largest human tissue providers, launched the AlloMend Duo Acellular Dermal Matrix (ADM), a natural alternative for soft tissue restoration. The AlloMend Duo ADM was developed to assist surgeons in the repair and reconstruction of soft tissue abnormalities for long-term structural stability. The deep reticular dermal allograft integrates with the surrounding tissue, and acts as scaffold for cell repopulation and regeneration of the native host tissues.

The properties of AlloMend Duo ADM provide several advantages, and this makes it suitable for use in a variety of health treatments that need the strength and biocompatibility of a human regenerating tissue matrix. The allograft is flexible and pliable, allowing for ideal handling and accurate implantation.

Key features of the study:

This report provides an in-depth analysis of the global acellular dermal matrices market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global acellular dermal matrices market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, CG bio Inc., and Marine Polymer Technologies, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global acellular dermal matrices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acellular dermal matrices market

Detailed Segmentation:

Global Acellular Dermal Matrices Market, By Origin:
- Human Dermis
- Porcine Dermis
- Bovine Dermis
Global Acellular Dermal Matrices Market, By Application:
- Acute Wounds
- Burns
- Trauma
- Cancers
- Infections
- Chronic Wounds
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcer
- Others
- Reconstruction Procedures
- Abdominal Wall Procedures
- Breast Procedures
- Orthopedic Procedures
- Others
Global Acellular Dermal Matrices Market, By Place of Setting:
- Hospitals
- In- patient
- Out- patient
- Ambulatory Surgical Centers
- Office Based
Global Acellular Dermal Matrices Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Integra LifeSciences Corporation
- AbbVie Inc.
- Johnson & Johnson
- HansBioMed
- Becton, Dickinson and Company
- Cook Group
- Smith & Nephew Plc.
- Reprise Biomedical
- Organogenesis Holdings Inc
- Tissue Regenix
- LifeNet Health
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation
- MiMedx Group
- PolyNovo Limited
- Fidia Pharma USA Inc.
- Baxter International Inc.
- In2Bones Global
- BioHorizons, Inc.
- Harbor MedTech, Inc.
- MLM Biologics Inc.
- Geistlich Pharma AG
- Olaregen Therapeutix, Inc.
- EnColl Corporation
- Kerecis limited
- DSM
- ACell Inc.
- 3M
- Cell Constructs I, LLC
- CG bio Inc.
- Marine Polymer Technologies, Inc.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Origin
- Market Snippet, By Application
- Market Snippet, By Place of Setting
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Recent Trend
Key Developments
Regulatory Scenario
PEST Analysis
PORTER's Analysis
Product Launches/Approvals Mergers, Acquisitions and Collaborations

4. Global Acellular Dermal Matrices Market- COVID-19 Impact Analysis

COVID-19 Epidemiology
Overall Impact on Healthcare Sector
Total Impact of COVID-19 on Global Acellular Dermal Matrices Market
Supply and Demand Analysis

5. Global Acellular Dermal Matrices Market, By Origin, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Human Dermis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 -2030, (US$ Bn)
Porcine Dermis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Bovine Dermis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Acellular Dermal Matrices Market, By Application, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Acute Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Burns
Trauma
Cancers
Infections
Chronic Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcer
Others
Reconstruction Procedures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Abdominal Wall Procedures
Breast Procedures
Orthopedic Procedures
Others

7. Global Acellular Dermal Matrices Market, By Place of Setting, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
In- patient
Out- patient
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Office Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Acellular Dermal Matrices Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 -2030, (US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- Integra LifeSciences Corporation
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- AbbVie Inc.
- Johnson & Johnson
- HansBioMed
- Becton, Dickinson and Company
- Cook Group
- Smith & Nephew Plc.
- Reprise Biomedical
- Organogenesis Holdings Inc.
- Tissue Regenix
- LifeNet Health
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation
- MiMedx Group
- PolyNovo Limited
- Fidia Pharma USA Inc.
- Baxter International Inc.
- In2Bones Global
- BioHorizons, Inc.
- Harbor MedTech, Inc.
- MLM Biologics Inc.
- Geistlich Pharma AG
- Olaregen Therapeutix, Inc.
- EnColl Corporation
- Kerecis limited
- DSM
- ACell Inc.
- 3M
- Cell Constructs I, LLC
- CG bio Inc.
- Marine Polymer Technologies, Inc.
Analysts' Views